Clinical Trials Browser

Capsules × Thoracic × 1 year × Clear all

NCT04105270 2025-09-11

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT03753685 2025-07-23

X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases

Phase 2 Active not recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung